Exploring the groundbreaking research on chemotherapy-induced peripheral neuropathy and the development of ART26.12, a novel FABP5 inhibitor offering new hope for cancer patients.
Explore how adaptive apparel is transforming cancer care by blending fashion with functionality to support both medical and emotional needs of chemotherapy patients.